Radiopharmaceutical PET/CT Ålesund Hospital - Helse Møre og Romsdal HF

Helse Møre og Romsdal HF, Ålesund Hospital has, since mid December 2021, run an offer with PET/CT. PET/CT is the most advanced image diagnostic examination method currently available. In order to carry out this survey, a radioactive preparation must be procured. There is currently only one commercial manufacturer in Norway, …

CPV: 33694000 Czynniki diagnostyczne
Miejsce wykonania:
Radiopharmaceutical PET/CT Ålesund Hospital - Helse Møre og Romsdal HF
Miejsce udzielenia zamówienia:
SYKEHUSINNKJØP HF
Numer nagrody:
2025/57683

1. Buyer

1.1 Buyer

Official name : SYKEHUSINNKJØP HF

1.1 Buyer

Official name : Helse Møre og Romsdal HF

2. Procedure

2.1 Procedure

Title : Radiopharmaceutical PET/CT Ålesund Hospital - Helse Møre og Romsdal HF
Description : Helse Møre og Romsdal HF, Ålesund Hospital has, since mid December 2021, run an offer with PET/CT. PET/CT is the most advanced image diagnostic examination method currently available. In order to carry out this survey, a radioactive preparation must be procured. There is currently only one commercial manufacturer in Norway, and due to its short shelf life/half-time, the products must be delivered on the same day it shall be used. Ålesund Hospital is dependent on deliveries of FDG on average 2-3 times a week with delivery by 10:00. GE Healthcare, which is located in Oslo, is the only supplier of FDG in Norway. The preparation SteriPET is a radioactive preparation with half the time, 110 minutes. The preparation ́s shelf life is 10 hours from the completed synthesis. In addition GE Healthcare produces 2 batches per day and quality assures the first delivery parallel to transporting it to the hospital. This ensures timely delivery. If batch no. 1 does not go through quality control, batch no. 2 will be at the hospital before 10:00.The total value of the procurement is estimated to be approx. The contracting authority will not enter into a contract with GE Healthcare AS until 1.11.25 At the earliest, Helse Møre og Romsdal HF (Ålesund Hospital) would like to carry out a direct procurement with GE in order to establish a framework agreement for the delivery of PET tracers as defined below, after a prior intention notice based on the argumentation above. The framework agreement will be valid for 1 year, as well as an option for a 1+1+1 year extension. Relevant products: 18F-2' – fluoro-2'-deoxyglukose (FDG)PSMA-1007 (18F) The procurement is located outside the scope of the procurement regulations. Reasons for awarding a contract without a competition notice: Based on market surveys, there is only one specific tenderer on the market in the EU/EEA who offers FDG within the given frameworks. The contracting authority therefore believes that it is necessary to enter into a contract without a competition in accordance with the procurement regulations § 13-4 first section, letter b no. 2.
Procedure identifier : 15141a11-b40f-43e4-8807-2a45c6fdfdba
Internal identifier : 2025/57683
Type of procedure : Negotiated without prior call for competition

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33694000 Diagnostic agents

2.1.2 Place of performance

Country subdivision (NUTS) : Møre og Romsdal ( NO0A3 )
Country : Norway

2.1.4 General information

Legal basis :
Directive 2014/24/EU
Anskaffelsesforskriften - Can only be delivered by one supplier

5. Lot

5.1 Lot technical ID : LOT-0000

Title : Radiopharmaceutical PET/CT Ålesund Hospital - Helse Møre og Romsdal HF
Description : Helse Møre og Romsdal HF, Ålesund Hospital has, since mid December 2021, run an offer with PET/CT. PET/CT is the most advanced image diagnostic examination method currently available. In order to carry out this survey, a radioactive preparation must be procured. There is currently only one commercial manufacturer in Norway, and due to its short shelf life/half-time, the products must be delivered on the same day it shall be used. Ålesund Hospital is dependent on deliveries of FDG on average 2-3 times a week with delivery by 10:00. GE Healthcare, which is located in Oslo, is the only supplier of FDG in Norway. The preparation SteriPET is a radioactive preparation with half the time, 110 minutes. The preparation ́s shelf life is 10 hours from the completed synthesis. In addition GE Healthcare produces 2 batches per day and quality assures the first delivery parallel to transporting it to the hospital. This ensures timely delivery. If batch no. 1 does not go through quality control, batch no. 2 will be at the hospital before 10:00.The total value of the procurement is estimated to be approx. The contracting authority will not enter into a contract with GE Healthcare AS until 1.11.25 At the earliest, Helse Møre og Romsdal HF (Ålesund Hospital) would like to carry out a direct procurement with GE in order to establish a framework agreement for the delivery of PET tracers as defined below, after a prior intention notice based on the argumentation above. The framework agreement will be valid for 1 year, as well as an option for a 1+1+1 year extension. Relevant products: 18F-2' – fluoro-2'-deoxyglukose (FDG)PSMA-1007 (18F) The procurement is located outside the scope of the procurement regulations. Reasons for awarding a contract without a competition notice: Based on market surveys, there is only one specific tenderer on the market in the EU/EEA who offers FDG within the given frameworks. The contracting authority therefore believes that it is necessary to enter into a contract without a competition in accordance with the procurement regulations § 13-4 first section, letter b no. 2.
Internal identifier : 2025/57683

5.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33694000 Diagnostic agents

5.1.2 Place of performance

Country subdivision (NUTS) : Møre og Romsdal ( NO0A3 )
Country : Norway
Additional information :

5.1.6 General information

The procurement is covered by the Government Procurement Agreement (GPA) : yes

5.1.16 Further information, mediation and review

Review organisation : Øst-Finnmark tingrett

6. Results

Direct award :
Justification for direct award : The contract can be provided only by a particular economic operator because of protection of other exclusive rights, including intellectual property rights, other than those defined in Directive 2014/23/EU Art. 5(10)
Other justification : Only one supplier in the market.

6.1 Result lot ldentifier : LOT-0000

6.1.2 Information about winners

Winner :
Official name : GE HealthCare
Tender :
Tender identifier : 2025/56783
Identifier of lot or group of lots : LOT-0000
Contract information :
Identifier of the contract : 2025/56783
Title : Steripet FDG
Date on which the winner was chosen : 07/10/2025

8. Organisations

8.1 ORG-0001

Official name : SYKEHUSINNKJØP HF
Registration number : 916879067
Postal address : Postboks 40
Town : VADSØ
Postcode : 9811
Country subdivision (NUTS) : Finnmark/Finnmárku/Finmarkku ( NO073 )
Country : Norway
Contact point : Postmottak Sykehusinnkjøp
Telephone : +47 78950700
Roles of this organisation :
Buyer
Group leader

8.1 ORG-0002

Official name : Øst-Finnmark tingrett
Town : VADSØ
Postcode : 9800
Country subdivision (NUTS) : Finnmark/Finnmárku/Finmarkku ( NO073 )
Country : Norway
Roles of this organisation :
Review organisation

8.1 ORG-0003

Official name : Helse Møre og Romsdal HF
Postal address : nybøveien 9
Town : Ålesund
Postcode : 6410
Country subdivision (NUTS) : Møre og Romsdal ( NO0A3 )
Country : Norway
Telephone : 71 12 00 00
Roles of this organisation :
Buyer

8.1 ORG-0004

Official name : GE HealthCare
Registration number : 914829674
Town : oslo
Postcode : 0401
Country subdivision (NUTS) : Oslo ( NO081 )
Country : Norway
Roles of this organisation :
Tenderer
Winner of these lots : LOT-0000

Notice information

Notice identifier/version : b15ab052-1f7c-4fd7-9b19-4ea52a4d0cbf - 01
Form type : Direct award preannouncement
Notice type : Voluntary ex-ante transparency notice
Notice dispatch date : 08/10/2025 13:13 +00:00
Notice dispatch date (eSender) : 08/10/2025 13:24 +00:00
Languages in which this notice is officially available : English
Notice publication number : 00665016-2025
OJ S issue number : 195/2025
Publication date : 10/10/2025